01259nam 2200349Ia 450 99638415230331620200824132637.0(CKB)4940000000075590(EEBO)2264194039(OCoLC)ocm12207312e(OCoLC)12207312(EXLCZ)99494000000007559019850627d1663 uy |engurbn||||a|bb|A Short surveigh of the grand case of the present ministry[electronic resource] whether they may lawfully subscribe and declare as by the late Act of uniformity is required, and the several cases thence arising, especially about the covenant /by some conformable non-conformists[S.l. s.n.]166347 pReproduction of original in Union Theological Seminary Library, New York.Work signed by M.D., S.C., I.F., O.R. and A.T.eebo-0160Dissenters, ReligiousEnglandDissenters, ReligiousM. D1001973EAAEAAm/cWaOLNBOOK996384152303316A Short surveigh of the grand case of the present ministry2403816UNISA01534nam 2200409I 450 991070276330332120150107075127.0(CKB)5470000002430565(OCoLC)899261014(EXLCZ)99547000000243056520150107d1961 ua 0engurbn|||||||||rdacontentrdamediardacarrierThe Virginia pine sawfly in 1960 a special cooperative report /T. McIntyre, R.C. Heller, C.L. MorrisUpper Darby, PA. :Forest Service, U.S. Dept. of Agriculture, Northeastern Forest Experiment Station,1961.1 online resource (7 pages) mapsForest research notes / Northeastern Forest Experiment Station ;no. 114Title from title screen (viewed Dec. 31, 2014).Publication pre-dates Federal Depository Library Program (FDLP) item numbers. No FDLP item number has been assigned.Virginia pine sawfly in 1960 SawfliesScrub pineDiseases and pestsHistorySawflies.Scrub pineDiseases and pestsHistory.McIntyre T.1419670Heller Robert Chester1918-Morris C. L.Northeastern Forest Experiment Station (Radnor, Pa.),GPOGPOBOOK9910702763303321The Virginia pine sawfly in 19603534921UNINA08523nam 2200769Ia 450 991097382610332120251017110113.0978661019303597803091765830309176581978128019303312801930349780309598620030959862197805851545720585154570(CKB)110986584751592(OCoLC)44960724(CaPaEBR)ebrary10057046(SSID)ssj0000153929(PQKBManifestationID)11946761(PQKBTitleCode)TC0000153929(PQKBWorkID)10406227(PQKB)11311572(MiAaPQ)EBC3376768(Au-PeEL)EBL3376768(CaPaEBR)ebr10057046(CaONFJC)MIL19303(OCoLC)923265953(Perlego)4735180(DNLM)788420(EXLCZ)9911098658475159219941206d1995 uy 0engurcn|||||||||txtccrFederal regulation of methadone treatment /Richard A. Rettig and Adam Yarmolinsky, editors ; Committee on Federal Regulation of Methadone Treatment, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine1st ed.Washington, D.C. National Academy Press19951 online resource (250 p.) Bibliographic Level Mode of Issuance: Monograph9780309052405 0309052408 Includes bibliographical references.Federal Regulation of Methadone Treatment -- Copyright -- Acknowledgments -- Contents -- Federal Regulation of Methadone Treatment -- Executive Summary -- HOW METHADONE IS REGULATED -- SCOPE OF THE REPORT -- BALANCING THE BENEFITS AND RISKS OF METHADONE -- RECOMMENDATIONS TO MODIFY AND SUPPLEMENT THE REGULATIONS -- Diagnosing Addiction and Determining Dose Levels -- Habilitative and Rehabilitative Services -- Treating Pregnant Opiate Addicts -- Replacing "Detoxification" with "Medically Supervised Withdrawal -- Inpatient Hospital Admissions -- Treating Opiate Addiction and Treating Pain -- ENFORCEMENT OF THE REGULATIONS -- GUIDELINES AND QUALITY ASSURANCE -- PROCESS EVALUATION AND OUTCOME EVALUATION -- FEDERAL GOVERNMENT LEADERSHIP -- REFERENCE -- 1 Introduction -- THE CHARGE TO THE COMMITTEE -- OBJECTIVES OF OPIATE ADDICTION TREATMENT -- EFFECTIVENESS OF METHADONE MAINTENANCE TREATMENT -- Beneficial Outcomes -- Factors Limiting Effectiveness -- Multiple Problems of Methadone Maintenance Patients -- Variability among Methadone Maintenance Programs -- WHY METHADONE IS REGULATED DIFFERENTLY FROM OTHER DRUGS -- THE COMMITTEE'S VIEW -- REPORT ORGANIZATION -- STUDY METHODS -- A NOTE ON TERMINOLOGY -- REFERENCES -- 2 Pharmacology and Medical Aspects of Methadone Treatment -- THE RATIONALE FOR PHARMACOTHERAPY -- History and Practice -- Basic Science -- PHARMACOKINETICS OF METHADONE -- METHADONE MAINTENANCE -- Treatment Regimen -- Effects, Side Effects, and Special Pharmacological Issues -- Physiological Functions Disrupted During Heroin Addiction -- INTERACTIONS OF METHADONE WITH OTHER DRUGS -- IMPACT OF METHADONE MAINTENANCE ON INFECTIOUS DISEASES -- REFERENCES -- 3 Who are the Recipients of Treatment? -- HEROIN USE AND DEPENDENCE -- Prevalence of Heroin Use -- From Use to Dependence -- How Persistent is Heroin Dependence?.Age, Gender, and Ethnicity -- Age -- Gender -- Ethnicity -- What Other Substances Do Heroin Users Consume? -- Other Medical and Social Problems of Heroin-Dependent Persons -- How Likely Are Heroin Addicts to Use Treatment? -- CHARACTERISTICS OF UNTREATED AND TREATED HEROIN ADDICTS -- METHADONE PATIENT CHARACTERISTICS -- Historical Trends -- Current Patient Characteristics -- Methadone in Drug Treatment: General -- Use of Methadone in Detoxification -- Use of Methadone in Maintenance Treatment -- Contrast between Detoxification and Maintenance Patient Admissions -- Maintenance Patients in New York State -- 1992 -- Maintenance Patients in California, 1992 -- Differences Between New York and California -- SUMMARY -- REFERENCES -- 4 Methadone Diversion Control -- EARLY CONCERN OVER DIVERSION -- THE NARCOTIC ADDICT TREATMENT ACT OF 1974 -- MORE RECENT OFFICIAL VIEWS ON DIVERSION -- House Select Committee Hearings -- Perspective of the Drug Enforcement Administration -- THE DATA ON DIVERSION -- Drug Abuse Warning Network Data -- Harris County, Texas -- Harris County Medical Examiner Data -- Methadone Maintenance Treatment Data -- Independent Pathologists' Review -- Drug Abuse Warning Network (DAWN) Medical Examiner Data -- Other Data on Diversion -- Drug Use Forecasting Data -- National AIDS Demonstration Research (NADR) Data -- HOW IS METHADONE DIVERTED? -- Production and Distribution System -- Sale by Patients: Who Sells and Why? -- WHO USES DIVERTED METHADONE AND WHY? -- CONSEQUENCES OF METHADONE DIVERSION -- Public Safety Issues -- Public Health Issues -- Is Diverted Methadone Dangerous? -- Is Diverted Methadone a Major Drug of Abuse? -- SUMMARY -- APPENDIX -- REFERENCES -- 5 Federal Regulation of Methadone Treatment -- THE 1960S -- THE NIXON ADMINISTRATION -- 1970 Legislation -- Special Action Office for Drug Abuse Presentation.DEFINING THE REGULATORY REGIME: 1970-1974 -- Research, Treatment, and Regulation -- Methadone IND Regulations -- 1972 Regulations -- Legal Challenge to the FDA -- Narcotic Addict Treatment Act of 1974 -- Summary: 1970-1974 -- THE CURRENT REGULATORY REGIME -- 1980 Revision of the Regulations -- 1989 Revision of the Regulations -- 1983 Regulatory Reform Initiative -- 1987 Notice of Proposed Rule-Making -- 1989 Final Rule -- 1989 Guidance Document -- 1989 Interim Methadone Maintenance Proposal -- Assessment of Program Performance -- LEVO-ALPHA-ACETYL-METHADOL -- SUMMARY -- REFERENCES -- 6 Methadone Treatment -- THE PROVIDER COMMUNITY -- Number of Treatment Facilities -- Regional Variation -- Number of Patients -- Capacity and Utilization Rate -- Waiting Lists -- Facility Ownership -- FINANCING OF METHADONE TREATMENT -- Department of Veterans Affairs -- Out-of-Pocket and Private Insurance -- STATE SUBSTANCE ABUSE AGENCIES -- New York -- Financing -- Regulations -- California -- Financing -- Regulations -- Florida -- Financing -- Regulations -- Illinois -- Financing -- Regulations -- Massachusetts -- Financing -- Regulations -- SUMMARY -- REFERENCES -- 7 Treatment Standards and Optimal Treatment -- DEFINITION OF TERMS -- PATIENT EVALUATION AND ADMISSION CRITERIA -- Admission to Medically Supervised Withdrawal -- Admission to Maintenance Pharmacotherapy -- Proper Patient Placement -- Two Conclusions -- MAINTENANCE PHARMACOTHERAPY -- Dosing -- Comprehensive Treatment Services -- Take-Home Medication -- Urine Testing -- Implications for Regulations -- Opiate Addiction in Pregnant Women -- MEDICALLY SUPERVISED WITHDRAWAL -- INPATIENT TREATMENT -- Maintenance Pharmacotherapy in Hospital Inpatient Settings -- Inpatients with Untreated Opiate Addiction -- PAIN MANAGEMENT -- Non-Opiate-Addicted Pain Patients -- Methadone Patients.''Recovering" Opiate and Other Substance Dependent Patients -- CONCLUDING COMMENTS -- REFERENCES -- 8 Implementing Standards-and Beyond -- REGULATIONS AND THEIR ENFORCEMENT -- CLINICAL PRACTICE GUIDELINES -- FORMAL QUALITY ASSURANCE SYSTEMS -- WHAT CAN BE DONE NOW? -- Process Evaluation -- Outcome Evaluation -- FEDERAL GOVERNMENT LEADERSHIP -- Research Issues -- Clinical Research -- Health Services Research -- Federal-State Relations -- Financing of Treatment -- Policy Guidance -- SUMMARY -- REFERENCES.Methadone maintenanceGovernment policyUnited StatesDrug monitoringGovernment policyUnited StatesMethadone hydrochlorideMethadone maintenanceGovernment policyDrug monitoringGovernment policyMethadone hydrochloride.353.0084/29Rettig Richard A1803761Yarmolinsky Adam675792Institute of Medicine (U.S.).Committee on Federal Regulation of Methadone Treatment.MiAaPQMiAaPQMiAaPQBOOK9910973826103321Federal regulation of methadone treatment4354272UNINA